[A long-term hemodialysis patient complicated with systemic calciphylaxis]. 1993

H Kaneda, and K Asahi, and K Sano, and K Shitomi, and T Murata, and M Nakayama
Department of Internal Medicine, Kashima Hospital, Fukushima, Japan.

A 46-year-old male patient underwent long-term hemodialysis treatment had suffered from calciphylaxis (defined by Selye), such symptoms as advanced systemic vascular calcification, rapid progression of gangrene on both fingers and toes, disturbance of consciousness, and sclerosis and obstruction of the superficial vein after venipuncture during 11.5 years of dialysis. Furthermore, he had a long history (30 years) of heavy smoking. He died as a result of sepsis due to pneumonia after 12.5 years of dialysis. He had received dialysis treatment using a small amount of dialysate (50 liters on a recirculating system) for 8.5 years and had been dialysed 2 and 2 or 3 times a week for 10 years. As a result of this insufficient dialysis treatment, his characteristic laboratory data showed hypocalcemia, hyperphosphatemia, elevated calcium-phosphorus product, advanced metabolic acidosis, hyperalkaliphosphatemia and elevated serum parathyroid hormone. Autopsy revealed the following: 1) enlargement parathyroid gland enlarged in two (4.0 g and 2.0 g, respectively) showing adenomatous hyperplasia presenting cord-like arrangement of chief cells and water-clear cells, 2) systemic medial calcification in radial, ulnar, renal, mesenteric and brain arteries, and 3) Berline-blue positive iron deposit in calcified arteries in mesenteric and parathyroid tissue. From these results, we concluded that factors (challengers) related to the appearance of calciphylaxis might be as follows: 1) advanced secondary hyperparathyroidism, 2) long-term uremic state, 3) administration of VD2 and VD3, 4) iron salt injection, and 5) a long history of heavy smoking. We speculated that these challengers might act synergistically to cause calciphylaxis.

UI MeSH Term Description Entries
D006962 Hyperparathyroidism, Secondary Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY. Secondary Hyperparathyroidism,Hyperparathyroidisms, Secondary,Secondary Hyperparathyroidisms
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002115 Calciphylaxis Condition of induced systemic hypersensitivity in which tissues respond to appropriate challenging agents with a sudden local calcification. Calcific Uraemic Arteriolopathy,Calciphylaxes,Idiopathic Calciphylaxis,Arteriolopathy, Calcific Uraemic,Calcific Uraemic Arteriolopathies,Calciphylaxis, Idiopathic,Uraemic Arteriolopathy, Calcific
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014511 Uremia A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms. Uremias

Related Publications

H Kaneda, and K Asahi, and K Sano, and K Shitomi, and T Murata, and M Nakayama
February 2009, Clinical nephrology,
H Kaneda, and K Asahi, and K Sano, and K Shitomi, and T Murata, and M Nakayama
November 1997, Vnitrni lekarstvi,
H Kaneda, and K Asahi, and K Sano, and K Shitomi, and T Murata, and M Nakayama
August 1997, Ryumachi. [Rheumatism],
H Kaneda, and K Asahi, and K Sano, and K Shitomi, and T Murata, and M Nakayama
January 2020, Journal of investigative medicine high impact case reports,
H Kaneda, and K Asahi, and K Sano, and K Shitomi, and T Murata, and M Nakayama
November 1990, [Hokkaido igaku zasshi] The Hokkaido journal of medical science,
H Kaneda, and K Asahi, and K Sano, and K Shitomi, and T Murata, and M Nakayama
January 1995, American journal of nephrology,
H Kaneda, and K Asahi, and K Sano, and K Shitomi, and T Murata, and M Nakayama
January 2005, Seminars in dialysis,
H Kaneda, and K Asahi, and K Sano, and K Shitomi, and T Murata, and M Nakayama
August 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation,
H Kaneda, and K Asahi, and K Sano, and K Shitomi, and T Murata, and M Nakayama
September 2011, Dermatology online journal,
H Kaneda, and K Asahi, and K Sano, and K Shitomi, and T Murata, and M Nakayama
November 2015, CEN case reports,
Copied contents to your clipboard!